(19)
(11) EP 3 302 437 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.12.2022 Bulletin 2022/51

(45) Mention of the grant of the patent:
16.11.2022 Bulletin 2022/46

(21) Application number: 16800777.1

(22) Date of filing: 27.05.2016
(51) International Patent Classification (IPC): 
A61K 9/127(2006.01)
A61K 9/08(2006.01)
A61P 1/04(2006.01)
A61P 9/10(2006.01)
A61P 25/00(2006.01)
A61P 25/08(2006.01)
A61P 25/18(2006.01)
A61P 25/24(2006.01)
A61P 25/30(2006.01)
A61K 31/352(2006.01)
A61K 9/00(2006.01)
A61P 3/04(2006.01)
A61P 19/02(2006.01)
A61P 25/04(2006.01)
A61P 25/16(2006.01)
A61P 25/22(2006.01)
A61P 25/28(2006.01)
A61P 25/36(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/127; A61K 31/352; A61K 9/08; A61K 9/0095; A61K 9/006; A61P 1/04; A61P 13/12; A61P 17/02; A61P 19/02; A61P 25/00; A61P 25/04; A61P 25/08; A61P 25/16; A61P 25/18; A61P 25/22; A61P 25/24; A61P 25/28; A61P 25/30; A61P 25/34; A61P 25/36; A61P 29/00; A61P 3/04; A61P 35/00; A61P 37/02; A61P 37/06; A61P 9/10
(86) International application number:
PCT/US2016/034565
(87) International publication number:
WO 2016/191651 (01.12.2016 Gazette 2016/48)

(54)

STABLE CANNABINOID FORMULATIONS

STABILE CANNABINOIDFORMULIERUNGEN

FORMULATIONS DE CANNABINOÏDES STABLES


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 28.05.2015 US 201514724351
31.07.2015 US 201514815936

(43) Date of publication of application:
11.04.2018 Bulletin 2018/15

(60) Divisional application:
22207141.7

(73) Proprietor: Radius Pharmaceuticals, Inc.
Boston, MA 02210 (US)

(72) Inventors:
  • VANGARA, Kiran, Kumar
    Chandler, AZ 85286 (US)
  • LI, Huaguang
    Chandler, AZ 85286 (US)
  • YAN, Ningxin
    Chandler, AZ 85286 (US)
  • NGUYEN, Hung, Q.
    Chandler, AZ 85286 (US)
  • GOSKONDA, Venkat, R.
    Chandler, AZ 85286 (US)

(74) Representative: Carpmaels & Ransford LLP 
One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A2-2012/071389
US-A1- 2004 138 293
US-A1- 2007 104 741
US-A1- 2013 296 415
US-A- 5 989 583
US-A1- 2006 160 888
US-A1- 2010 273 895
US-A1- 2015 342 902
   
  • MORGAN ET AL.: 'Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings.' ADDICT BEHAV. vol. 38, no. 9, September 2013, pages 2433 - 2436, XP028564804
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).